共 50 条
The Importance of Cell Saver Usage in Complex Endovascular Repair of Thoraco-Abdominal Aortic Aneurysms
被引:1
|作者:
Ali, Ahmed A.
[1
,2
]
Hamwi, Tarek
[1
]
Sikman, Laura
[1
]
Stana, Jan
[1
]
Abicht, Jan-Michael
[3
]
Tsilimparis, Nikolaos
[1
]
Prendes, Carlota F.
[1
]
机构:
[1] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Vasc Surg Vasc & Endovasc Surg, D-81377 Munich, Germany
[2] Mansoura Univ, Univ Hosp, Dept Vasc Surg Vasc & Endovasc Surg, Mansoura, Egypt
[3] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Anesthesiol, Munich, Germany
关键词:
REPORTING STANDARDS;
BLOOD;
TRANSFUSION;
COST;
D O I:
10.1016/j.avsg.2024.06.027
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Background: The use of the cell saver is well-established in open aneurysm repair; however, its role in endovascular repair is yet to be determined. The aim of this study was to analyze the effects of cell saver usage in patients undergoing complex endovascular procedures. Materials and methods: Single-center retrospective cohort study, including consecutive patients undergoing fenestrated and/or branched repair for the treatment of thoracoabdominal and complex abdominal aortic aneurysms (CAAAs) between January 2019 and December 2022. The cell saver was a standard part of the intraoperative setup of these procedures, and its use was readily available. The primary endpoint was the percentage of patients, in which autologous blood collected was transfused (cell saver blood transfusion [CSBT]), alongside the useable amount obtained. Secondary endpoints included mean blood loss, postoperative hemoglobin levels, and 30-day mortality. Results: A total of 170 patients (77.1% male, mean age 71.2 +/- 9.2 years) were included, with a median blood loss of 700 mL (interquartile range [IQR] 400-1,200- 1,200 mL). A total of 96 patients received some kind of blood transfusion (BT) (56.5%): 35 patients were (20.6%) allogenic BT, 31 patients were (18.2%) CSBT only, and 30 patients were (17.6%) a combination of both. In total, 61 patients (35.9% or 63.5% of all patients requiring BTs) received CSBT, with a median useable blood volume of 282 mL (IQR, 194.5-508- 508 mL). Thirty-day mortality was similar in both groups. Although the CSBT group had lower intraoperative hemoglobin values (9.25 +/- 1.55 vs. 10.36 +/- 1.88 mg/dL; P < 0.001), both groups presented similar postoperative hemoglobin (Hb) levels. Conclusions: Blood loss during complex endovascular repair is not insignificant. In this cohort, over 50% of included patients required some kind of BT, 32.3% of which received exclusively CSBT, while 31.3% had supplementary CSBT alongside allogenic BT. This data showcases its potential role in these repairs, paving the way for its standardization in the intraoperative setup of these complex procedures.
引用
收藏
页码:297 / 308
页数:12
相关论文